Jie Huang

Jie Huang, Shuang Yang, Xiao-yan Yang, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of a biosimilar of denosumab (LY06006): a randomized, double-blind, single-dose, parallel-controlled clinical study in healthy Chinese subjects

C. Dou, Jie Huang, Shuang Yang, 2022, Expert opinion on investigational drugs.

QL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects

Saqib Ali, Jie Huang, Shuang Yang, 2020, Expert opinion on biological therapy.

Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers

Xiaoping Zhou, M. Zhang, Hui Wang, 2022, Neurology and Therapy.

Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions

Jie Huang, Shuang Yang, Guo-ping Yang, 2021, Drug design, development and therapy.

Semi-Mechanistic Modeling of HY-021068 Based on Irreversible Inhibition of Thromboxane Synthetase

Ping Li, Guoping Yang, Jie Huang, 2020, Frontiers in Pharmacology.

Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study

Jie Huang, Shuang Yang, Chang Cui, 2019, Drug design, development and therapy.

DDDT_A_224553 4135..4144

Jie Huang, Shuang Yang, Chang Cui, 2019 .

Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers

Chengxian Guo, Guoping Yang, Jie Huang, 2020, British journal of clinical pharmacology.

Rare ocular toxicity induced by pertuzumab/QL1209 in healthy chinese subjects: case reports and whole-exome sequencing analysis

Chengxian Guo, Jie Huang, Chan Zou, 2022, Investigational New Drugs.

Impact of NR1I2, adenosine triphosphate–binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers

Yicheng Wang, Yaqin Wang, Guoping Yang, 2018, Journal of ginseng research.

Yicheng Wang, Yaqin Wang, Guoping Yang, 2017, Front. Pharmacol..

Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects

Jie Huang, Shuang Yang, Xiao-yan Yang, 2020, Cancer Chemotherapy and Pharmacology.

Simultaneous Determination of Trantinterol and One of Its Major Metabolites, 1-Carbonyl Trantinterol, in Human Plasma by LC-MS-MS.

Guoping Yang, Jie Huang, Q. Pei, 2015, Journal of chromatographic science.

Safety, Pharmacokinetics/Pharmacodynamics, and Absolute Bioavailability of Dexmedetomidine Hydrochloride Nasal Spray in Healthy Subjects: A Randomized, Parallel, Escalating Dose Study

Jie Huang, Shuang Yang, Xing-fei Zhang, 2022, Frontiers in Pharmacology.

Evaluation of the Highly Variable Agomelatine Pharmacokinetics in Chinese Healthy Subjects to Support Bioequivalence Study

Chengxian Guo, Ran-ran Zhang, Jie Huang, 2014, PloS one.

Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects

Guoping Yang, Jie Huang, Yun Kuang, 2020, Journal of asthma and allergy.

First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjects

Yu Cao, Y. Hua, Chengxian Guo, 2020, Investigational New Drugs.

Pharmacokinetics and bioequivalence of low-dose clopidogrel in healthy Chinese volunteers under fasted and fed conditions.

Chengxian Guo, Chengxiao Fu, Guoping Yang, 2019, Drug metabolism and pharmacokinetics.

A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects

Jie Huang, Shuang Yang, Xing-fei Zhang, 2020, Cancer Chemotherapy and Pharmacology.

Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary Syndrome

Jie Huang, Q. Xiang, Yi-min Cui, 2023, Clinical Pharmacokinetics.

A randomized, double-blind, parallel control study to evaluate the biosimilarity of QL1209 with Perjeta® in healthy male subjects

Jie Huang, Shuang Yang, Xiao-yan Yang, 2022, Frontiers in Pharmacology.

A pharmacokinetic study to comparatively evaluate the bioequivalence and safety of a humanized recombinant monoclonal antibody targeting human epidermal growth factor receptor-2 with the reference Herceptin in healthy Chinese subjects

Guoping Yang, Jie Huang, Shuang Yang, 2022, Investigational New Drugs.

Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration.

Guoping Yang, Jie Huang, Shuang Yang, 2020, Pulmonary pharmacology & therapeutics.

Genotype-Guided Dosing of Warfarin in Chinese Adults

Jingjing Cai, Chengxian Guo, Honghao Zhou, 2020, Circulation. Genomic and precision medicine.

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers

Chengxian Guo, Jie Huang, Chan Zou, 2022, Frontiers in Pharmacology.

Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single‐Dose, 3‐Period Crossover Study

Jie Huang, Shuang Yang, Xing-fei Zhang, 2020, Clinical pharmacology in drug development.

Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

Chengxian Guo, J. Gu, Guoping Yang, 2016, Acta Pharmacologica Sinica.

Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single‐center, open‐label phase I trial

Jie Huang, Shuang Yang, Xiao-yan Yang, 2022, Cancer medicine.

Pharmacokinetics of single-dose morinidazole in patients with severe renal impairment.

H. Zhang, Jie Huang, Guo-ping Yang, 2014, International journal of clinical pharmacology and therapeutics.

Jie Huang, Shuang Yang, Xiao-yan Yang, 2022, Expert opinion on investigational drugs.

Impact of polymorphisms in angiogenesis‐related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma

Rong Liu, Li-Hua Huang, Chengxian Guo, 2017, Clinical and experimental pharmacology & physiology.

Dose Investigation of Imrecoxib in Patients with Renal Insufficiency Based on Modelling and Simulation.

Guoping Yang, Jie Huang, Q. Pei, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Simultaneous determination of Pyragrel, a novel anti‐thrombotic agent, and its two primary metabolites in plasma by HPLC–MS/MS

Chengxiao Fu, Guoping Yang, Jie Huang, 2018, Journal of pharmaceutical and biomedical analysis.

Profiling and Preparation of Metabolites from Pyragrel in Human Urine by Online Solid-Phase Extraction Coupled with High Performance Liquid Chromatography Tandem Mass Spectrometry Followed by a Macroporous Resin-Based Purification Approach

Jie Huang, Zhaoxing Chu, T. Hang, 2017, Molecules.

Pharmacokinetic study of imrecoxib in patients with renal insufficiency

Wei Li, Jie Huang, Xiao-yan Yang, 2019, European Journal of Clinical Pharmacology.

Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study.

H. Zhang, Jun Liu, Jie Huang, 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose

Chengxian Guo, Jie Huang, Shuang Yang, 2020, British journal of clinical pharmacology.

The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers

Jie Huang, Q. Xiang, Xia Zhao, 2023, Clinical Drug Investigation.

Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial

Jie Huang, Shuang Yang, Guoping Yang, 2024, Drug design, development and therapy.

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects

Xuqing Zhang, Jie Huang, Shuang Yang, 2023, Drug design, development and therapy.